For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions
The market is expected to increase over the forecast period. With the ongoing development of new and innovative BIOs, the market is expected to experience moderate growth as physicians upgrade their devices. This will lead to a slight increase in unit sales. There were approximately 18,000 practicing ophthalmologists in the United States that year. Although there were fewer ophthalmologists than optometrists, each ophthalmologist had, on average, 3.5 lanes in their practice. Every lane requires a binocular indirect ophthalmoscope. As a result, the demand for BIOs is higher among ophthalmologists.
Binocular indirect ophthalmoscopes (BIOs) are used by all optometrists and ophthalmologists and are needed in every practice, as well as in every lane of a practice. In 2016, there were approximately 40,000 optometrists and 18,000 practicing ophthalmologists in the United States. Typically, the average optometrist has 1.5 lanes in their practice and the average ophthalmologist has 3.5 lanes.
Carl Zeiss Meditec
Bausch & Lomb
Others Include: Bioptigen, Bon Optic, CentreVue, Huvitz, iOptics, iViews, JEDMED, Meda, Medmont, Modernizing Medicine, Nianjing RedSun Optical, Nikon, Opto Global, Optomed, Paradigm, Propper Manufacturing, Shin Nippon, Sonogage, Tracey Technologies, Volk, Welch-Allyn, etc.